kpi-121
kala pharmaceuticals
['ibd']
calprotectin-g patients with early treatment treat to target adequate monitoring with endoscopic/radiologic/biologic markers. not all symptoms are ibd. rely on the markers. maintain steroid-free remission
#acg2022 #ibd #womeningi 
Internal Medicine Resident Physician @svhmedres | Interested in Gastroenterology